Aloxistatin (E64d)
Aloxistatin (E64d) is an irreversible and membrane-permeable cysteine protease inhibitor with blood platelet aggregation inhibiting activity. The cysteine protease cathepsin L is required for SARS-CoV-2 viral entry, and aloxistatin treatment reduced cellular entry of SARS-CoV-2 pseudovirions by 92.3%.
Trivial name | E-64d |
Catalog Number | S7393 |
Molecular Formula | C17H30N2O5 |
CAS# | 88321-09-9 |
Inchi | InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1 |
Inchi Key | SRVFFFJZQVENJC-IHRRRGAJSA-N |
SMILES | CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C |
Size | 2mg |
Supplier Page | http://www.selleckchem.com/products/Aloxistatin.html |
Additional Information | https://file.selleck.cn/downloads/struct/E-64d-Aloxistatin-Loxistatin-chemical-structure-s7393.gif |